, arterial blood gas analysis (oxygen 2 L/min, 29%) displaying PH value 7.461 (7.35-7.45), SO 2 value 99.6% (95%-98%), PO 2 value 111 mmHg (80-100 mmHg), PCO 2 value 23 mmHg (35~45 mmHg)), HCO-3 value 18.4 mmom/L (24.1-27.3 mmol/L), blood urine nitrogen (BUN) value 13.3 mnol/L (2.5-7.8 mnol/L), computed tomography (CT) of the chest and abdomen showing pulmonary infection, massive pleural effusion and atelectasis ( Figure 1A ), blurring and swelling of peritoneum ( Figure 1B ), few ascites ( Figure 1C ) and few pelvic effusion ( Figure 1D ). She was diagnosed with acute multi-organ dysfunction caused by complications of INF-a therapy. Therefore, INF-a was discontinued immediately. The patient received blood products transfusion, liver protection and antibiotics were treated. For 10 days, she recovered uneventfully. However, she refused digestive endoscope and bone marrow biopsy. One month later, laboratory values were normal. In conclusion, it is necessary to monitor blood counts, liver function and kidney function due to side effects of the recent use of INF-a. 
of 16.6 µmol/L (3.4-21.0 µmol/L), AST of 742.4 U/L (0-39 U/L), ALT of 3908 U/L (0-40 U/L), fecal occult blood test (+++), arterial blood gas analysis (oxygen 2 L/min, 29%) displaying PH value 7.461 (7.35-7.45), SO 2 value 99.6% (95%-98%), PO 2 value 111 mmHg (80-100 mmHg), PCO 2 value 23 mmHg (35~45 mmHg)), HCO-3 value 18.4 mmom/L (24.1-27.3 mmol/L), blood urine nitrogen (BUN) value 13.3 mnol/L (2.5-7.8 mnol/L), computed tomography (CT) of the chest and abdomen showing pulmonary infection, massive pleural effusion and atelectasis ( Figure 1A ), blurring and swelling of peritoneum ( Figure 1B ), few ascites ( Figure 1C ) and few pelvic effusion ( Figure 1D ). She was diagnosed with acute multi-organ dysfunction caused by complications of INF-a therapy. Therefore, INF-a was discontinued immediately. The patient received blood products transfusion, liver protection and antibiotics were treated. For 10 days, she recovered uneventfully. However, she refused digestive endoscope and bone marrow biopsy. One month later, laboratory values were normal. In conclusion, it is necessary to monitor blood counts, liver function and kidney function due to side effects of the recent use of INF-a. Interferon-a (INF-a) is a cytokine associated with early viral infection, has both anti-viral and anti-proliferative properties and commonly use in the treatment of various virus infection disorder, such as hepatitis C (HCV) and human papillomavirus (HPV) [1] . The most common acute side effects are flu-like symptoms, while chronic side effects include hematologic, neuropsychiatric and endocrinological (mainly thyroid) [2] . In this case, we reported acute multi-organ dysfunction during INF-a therapy. A 16-year-old HPVpositive woman presented with a 4-month history of condylomata acuminate on the vulva and received surgical therapy combined with subcutaneous INF-a (300 iu, once a day). Nine days later, she developed gastrointestinal hemorrhage, abdominal pain, high fever and chest tightness shortness of breath. Subsequently, she was admitted to hospital in intensive care unit. On physical examination, she had high-grade fever (39.5C), respiratory rate 22 per minute, heart rate 110 per minute, blood pressure 90/60 mmHg, severe pallor, double pulmonary moist rales, lower abdominal tenderness and rebound tenderness. 
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